The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2025

Filed:

Jan. 27, 2023
Applicant:

Evecxia Therapeutics, Inc., Research Triangle Park, NC (US);

Inventor:

Jacob Pade Ramsoe Jacobsen, Durham, NC (US);

Assignee:

Evecxia Therapeutics, Inc., Research Triangle Park, NC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 9/00 (2006.01); A61K 31/198 (2006.01); A61K 31/405 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/405 (2013.01); A61K 9/0065 (2013.01); A61K 9/2013 (2013.01); A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61K 9/2086 (2013.01); A61K 31/198 (2013.01); A61K 45/06 (2013.01);
Abstract

A gastroretentive, sustained-release dosage form including 5-hydroxytryptophan (5-HTP) as an active ingredient and low-dose carbidopa is described. For example, the dosage form can be provided as a bilayer tablet comprising a swelling layer and a modified release layer, where the 5-HTP and carbidopa are both included in the modified release layer. The dosage form provides for essentially parallel release of the 5-HTP and the carbidopa with, for instance, release of 80% of the 5-HTP and carbidopa at about 5 hours to about 12 hours. Methods of elevating 5-HTP plasma exposure are also described.


Find Patent Forward Citations

Loading…